Bayer Crop Science Q3 FY26 – Margins Improve Sharply

Bayer Crop Science reported a steady December 2025 quarter. While revenue growth was modest, profitability improved significantly on a year-on-year basis, indicating better margins and operating efficiency. • Sales: ↑ 5% YoY to ₹1,106 crore (vs ₹1,057 crore in Dec 2024) • EBIDT: ↑ 480% YoY to ₹117 crore (vs ₹20.2 crore) • Net Profit: ↑ 180% YoY to ₹95.7 crore (vs ₹34.2 crore) • EPS: ↑ 180% YoY to ₹21.29 (vs ₹7.61) At a price of ₹4,762, market cap ₹21,455 crore, and PE 32, Bayer Crop Science is showing strong improvement in profitability despite limited top-line growth. Overall, the quarter reflects margin recovery and operational strength, though consistent revenue growth will be important for sustained long-term momentum.